David Fruman, Ph.D., Professor in the Department of Molecular Biology & Biochemistry in the School of Biological Sciences at UC Irvine. Previously, he served as the director of the Cellular & Molecular Biosciences (CMB) interdepartmental Ph.D. program.
Harinder Singh, Ph.D., Received his Doctorate in Cardiovascular biology from Temple University School of Medicine, Philadelphia (2014) and conducted Postdoctoral training in Neurosciences at University of Illinois at Chicago (UIC) until Oct 2018. Former President of Postdoctoral Association at UIC, he has experience in career development programming for graduate students and postdoctoral fellows. He served many roles at the Chicago based Scientist organization, CHIentist, dedicated to providing a networking platform for junior researchers and industry professionals, allowing parallel growth. Currently, he is serving on the board of directors of science advocacy organization, Future of Research, which serves to engage and empower early career scientists with evidence based resources to improve the scientific research endeavor. He has experience working with diverse groups of students and is passionate about increasing professional development opportunities for junior researchers. Currently, as the leader of UC Irvine’s NIH-BEST program, he is dedicated to finding solutions that broaden research training for PhDs, foster relationships between academia and the private sector and raise awareness of how academic discoveries advance society.
Contact Information: 3221 McGaugh Hall, Irvine, CA 92697, (949) 824-8372 (office), email@example.com
Emma Flores-Kim, PhD., served as Associate Director of GPS-BIOMED program until September 2018. She received her doctorate in neurosciences from Northwestern University, Chicago. She also served as Co-director of bioEXCEL and chemEXCEL, summer bridge programs designed to prepare incoming freshman of diverse background for success at Northwestern University.
Currently, she is a Medical Writer at NeoTract, responsible for preparing, editing, and reviewing publications, reports, and scientific literature reviews. She collaborates with cross-functional teams to drive the dissemination of clinical publications for Class II medical device products.
Karina Cramer, Ph.D., Associate Professor in the Department of Neurobiology & Behavior in the School of Biological Sciences
Andrej Luptak, Ph.D., Associate Professor of Pharmaceutical Sciences, Chemistry, and Molecular Biology and Biochemistry
John Lowengrub, Ph.D., Chancellor’s Professor in the Departments of Mathematics, Biomedical Engineering, and Chemical Engineering and Materials Science
Christopher Vanderwal, Ph.D., Associate Professor of Chemistry and Chancellor’s Faculty Fellow
Christine E. McLaren, Ph.D., Professor and Vice Chair for Faculty Affairs, Department of Epidemiology
Ulrike Luderer, MD, Ph.D., MPH, Associate Professor of Medicine in the School of Medicine and holds secondary appointments in Developmental and Cell Biology and the Program in Public Health
Frithjof Kruggel, MD, Ph.D, Professor in the Department of Biomedical Engineering
Oladele Ogunseitan, Ph.D., MPH, Professor of Public Health and Director of Research, Education, Training and Career Development for the Institute for Clinical and Translational Science (ICTS)